We can reduce the rates of colorectal cancer by improving early detection and screening.
Colorectal cancer is the second leading cause of cancer death in the United States and a leading cause of years of life lost to cancer in San Francisco.
Screening detects precancerous polyps before cancer can develop, as well as early stage cancers at a time when they can be cured. It is one of the most effective ways to prevent colorectal cancer deaths.
As colorectal cancer screening rates have increased locally and nationally, incidence and mortality from colorectal cancer has started to decline.
UCSF is committed to supporting the 80 by 18 campaign in San Francisco. 80 by 18 means raising the screening rate to 80% of eligible adults by 2018. Many of San Francisco’s health systems are already close to this level of screening, but there is still much to do , particularly among the underinsured and those who belong to medically vulnerable groups served by safety net clinics.
In our first year, SF-CAN will support safety net clinics belonging to the San Francisco Community Clinic Consortium. This includes technical assistance to increase screening rates, thorough reporting systems, and improving patient navigation to ensure that people with abnormal screening tests receive timely follow up.
UCSF, the American Cancer Society, San Francisco Health Plan, Zuckerberg San Francisco General Hospital, and other community stakeholders are partnering in these efforts.